Skip to main content
Year archive

Sinco Pharmaceuticals Holdings Limited — 2020 filings

All 148 regulatory filings released by Sinco Pharmaceuticals Holdings Limited (6833) in 2020, sourced directly from the official regulator.

148 Filings
2020 Period
2020 filings (148)
Filing Released Lang
CHANGE IN ACCOUNTING POLICIES
Regulatory Filings
2020-12-31 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-12-31 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-12-31 English
VOLUNTARY ANNOUNCEMENT - "CISATRACURIUM BESYLATE INJECTION" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-12-28 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "ESOMEPRAZOLE SODIUM FOR INJECTION"
Regulatory Filings
2020-12-21 English
VOLUNTARY ANNOUNCEMENT - "OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-12-14 English
VOLUNTARY ANNOUNCEMENT - "IODIXANOL INJECTION" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-12-09 English
VOLUNTARY ANNOUNCEMENT - CAPITAL CONTRIBUTION TO SINOVAC LIFE SCIENCES CO., LTD
Capital/Financing Update
2020-12-06 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "PANTOPRAZOLE SODIUM FOR INJECTION"
Regulatory Filings
2020-12-01 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2020-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2020
Regulatory Filings
2020-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2020
Share Issue/Capital Change
2020-12-01 English
THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER, 2020
Interim / Quarterly Report 9M 2020
2020-11-30 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings
2020-11-20 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-11-18 English
VOLUNTARY ANNOUNCEMENT - "POMALIDOMIDE CAPSULES" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-11-13 English
VOLUNTARY ANNOUNCEMENT - LATEST INFORMATION REGARDING THE STUDY OF PENPULIMAB FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSIC HODGKIN LYMPHOMA PRESENTED AT SITC 2020
Regulatory Filings
2020-11-12 English
VOLUNTARY ANNOUNCEMENT - LATEST INFORMATION REGARDING THE STUDY OF PENPULIMAB FOR TREATMENT OF PATIENTS WITH METASTATIC NASOPHARYNGEAL CARCINOMA WHO HAD PROGRESSED AFTER TWO OR MORE LINES OF CHEMOTHER
Regulatory Filings
2020-11-12 English
UPDATE ON DIRECTOR'S INFORMATION PURSUANT TO RULE 13.51B(2) AND RULE 13.51(2)(l) OF THE LISTING RULES
Board/Management Information
2020-11-09 English
APPOINTMENT OF CO-CHIEF EXECUTIVE OFFICER
Board/Management Information
2020-11-06 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "BORTEZOMIB FOR INJECTION"
Regulatory Filings
2020-11-05 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "ESOMEPRAZOLE SODIUM FOR INJECTION"
Regulatory Filings
2020-11-05 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION"
Regulatory Filings
2020-11-04 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR GANIRELIX ACETATE INJECTION
Regulatory Filings
2020-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2020
Share Issue/Capital Change
2020-11-02 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-11-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2020
Capital/Financing Update
2020-11-02 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR LENALIDOMIDE CAPSULES
Regulatory Filings
2020-10-29 English
VOLUNTARY ANNOUNCEMENT - "TDI01" OBTAINED APPROVAL FOR CLINICAL TRIAL FROM CDE
Regulatory Filings
2020-10-28 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2020-10-27 English
VOLUNTARY ANNOUNCEMENT - PENPULIMAB OBTAINED FAST TRACK DESIGNATION FROM FDA FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA
Regulatory Filings
2020-10-27 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-10-23 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2020-10-23 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR ROSUVASTATIN CALCIUM TABLET
Regulatory Filings
2020-10-22 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR CAPECITABINE TABLETS
Regulatory Filings
2020-10-20 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-10-16 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT IN PHASE III CLINICAL TRIAL IN COMBINATION WITH CHEMOTHERAPY FOR 1L METASTATIC SQUAMOUS NSCLC WITH PENPULIMAB
Regulatory Filings
2020-10-12 English
VOLUNTARY ANNOUNCEMENT - REGISTRATIONAL CLINICAL TRIAL FOR THIRD-LINE TREATMENT OF NASOPHARYNGEAL CANCER WITH PENPULIMAB REACHED KEY ENDPOINTS
Regulatory Filings
2020-10-12 English
VOLUNTARY ANNOUNCEMENT - "CANAGLIFLOZIN TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-10-09 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2020
Regulatory Filings
2020-10-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2020
Share Issue/Capital Change
2020-10-05 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS
Report Publication Announcement
2020-09-23 English
2020 INTERIM REPORT
Interim / Quarterly Report H1 2020
2020-09-23 English
2020 INTERIM REPORT
Interim / Quarterly Report
2020-09-17 English
VOLUNTARY ANNOUNCEMENT - "SPIRONOLACTONE TABLETS" OBTAINS APPROVAL FOR NEW INDICATION
Regulatory Filings
2020-09-15 English
VOLUNTARY ANNOUNCEMENT - "SAXAGLIPTIN TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-09-14 English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPLICATION OF "TDI01" ACCEPTED BY CDE
Regulatory Filings
2020-09-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2020
Capital/Financing Update
2020-09-01 English
VOLUNTARY ANNOUNCEMENT - "FULVESTRANT INJECTION" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-09-01 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-09-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2020
Capital/Financing Update
2020-09-01 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020
Interim / Quarterly Report
2020-08-28 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-08-28 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE, 2020
Interim / Quarterly Report H1 2020
2020-08-28 English
APPOINTMENT OF EXECUTIVE DIRECTOR, REDESIGNATION OF DIRECTOR AND CHANGE OF CHIEF EXECUTIVE OFFICER
Board/Management Information
2020-08-21 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE APPOINTMENT OF EXECUTIVE DIRECTOR, REDESIGNATION OF DIRECTOR AND CHANGE OF CHIEF EXECUTIVE OFFICER
Board/Management Information
2020-08-20 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-08-19 English
APPOINTMENT OF EXECUTIVE DIRECTOR, REDESIGNATION OF DIRECTOR AND CHANGE OF CHIEF EXECUTIVE OFFICER
Board/Management Information
2020-08-19 English
DATE OF BOARD MEETING
Regulatory Filings
2020-08-18 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "ADEFOVIR DIPIVOXIL CAPSULES"
Regulatory Filings
2020-08-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2020
Share Issue/Capital Change
2020-08-03 English
VOLUNTARY ANNOUNCEMENT "RIVAROXABAN TABLET" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-08-03 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-08-03 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-08-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2020
Share Issue/Capital Change
2020-08-03 English
VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE TABLET" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2020-07-31 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2020-07-30 English
VOLUNTARY ANNOUNCEMENT - "IDARUBICIN HYDROCHLORIDE FOR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-07-29 English
INSIDE INFORMATION - PLACING OF EXISTING SHARES BY A SHAREHOLDER
Transaction in Own Shares
2020-07-24 English
ADJUSTMENT TO CONVERSION PRICE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-07-21 English
2019 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2020-07-20 English
APPOINTMENT OF AUDITORS
Board/Management Information
2020-07-20 English
ADJUSTMENT TO CONVERSION PRICE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-07-20 English
MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2020-07-15 English
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 15 JULY 2020
Declaration of Voting Results & Voting Rights Announcements
2020-07-15 English
VOLUNTARY ANNOUNCEMENT - "IOPAMIDOL INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-07-14 English
CHANGE OF AUDITORS
Regulatory Filings
2020-07-08 English
VOLUNTARY ANNOUNCEMENT "INVERT SUGAR INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-07-06 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2020-07-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2020
Share Issue/Capital Change
2020-07-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2020
Share Issue/Capital Change
2020-07-02 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 JUNE 2020
Declaration of Voting Results & Voting Rights Announcements
2020-06-23 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2020-06-23 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS
Report Publication Announcement
2020-06-23 English
FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement
2020-06-23 English
PROPOSED BONUS ISSUE OF SHARES PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Share Issue/Capital Change
2020-06-23 English
1. PROPOSED BONUS ISSUE OF SHARES 2. PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL
Capital/Financing Update
2020-06-10 English
VOLUNTARY ANNOUNCEMENT - "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2020
Share Issue/Capital Change
2020-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2020
Major Shareholding Notification
2020-06-01 English
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH, 2020
Interim / Quarterly Report Q1 2020
2020-05-28 English
VOLUNTARY ANNOUNCEMENT - "EDARAVONE AND SODIUM CHLORIDE INJECTION" OBTAINS APPROVAL FOR NEW INDICATION
Regulatory Filings
2020-05-27 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 26 MAY 2020
Declaration of Voting Results & Voting Rights Announcements
2020-05-26 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF PENPULIMAB ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2020-05-26 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
AGM Information
2020-05-22 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-05-22 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2020-05-22 English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON RESULTS FROM CLINICAL TRIALS OF PENPULIMAB IN COMBINATION WITH ANLOTINIB FOR 1L HCC ACCEPTED FOR POSTER PRESENTATION AT THE 2020 ASCO ANNUAL MEETING
Regulatory Filings
2020-05-19 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-05-11 English
Annual Report 2019
Annual Report
2020-05-05 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2020
Share Issue/Capital Change
2020-05-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2020
Regulatory Filings
2020-05-04 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS
Report Publication Announcement
2020-04-21 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)
AGM Information
2020-04-21 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-04-21 English
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-04-21 English
2019 ANNUAL REPORT
Annual Report FY 2019
2020-04-21 English
INSIDE INFORMATION PLACING OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER
Major Shareholding Notification
2020-04-21 English
SUPPLEMENTAL AND CLARIFICATION ANNOUNCEMENT REGARDING THE PUBLISHED UNAUDITED ANNUAL RESULTS AND UPDATE ON THE AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Regulatory Filings
2020-04-17 English
VOLUNTARY ANNOUNCEMENT - "VILDAGLIPTIN TABLETS" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-04-16 English
DATE OF BOARD MEETING AND UPDATE OF PUBLICATION OF AUDITED ANNUAL RESULTS
Report Publication Announcement
2020-04-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2020
Share Issue/Capital Change
2020-04-01 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2020-04-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2020
Share Issue/Capital Change
2020-04-01 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2020-03-31 English
ANNOUNCEMENT OF UNAUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Interim / Quarterly Report
2020-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 2019
Annual Report FY 2019
2020-03-30 English
VOLUNTARY ANNOUNCEMENT - "DABIGATRAN ETEXILATE CAPSULES" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-03-20 English
DATE OF BOARD MEETING
Report Publication Announcement
2020-03-18 English
VOLUNTARY ANNOUNCEMENT - COLLABORATION IN AI TECHNOLOGY FOR INNOVATIVE ONCOLOGY DRUG DISCOVERY
Regulatory Filings
2020-03-17 English
VOLUNTARY ANNOUNCEMENT - "MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-03-09 English
POSITIVE PROFIT ALERT OF THE RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Earnings Release
2020-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2020
Capital/Financing Update
2020-03-03 English
VOLUNTARY ANNOUNCEMENT - "MONTELUKAST SODIUM ORAL GRANULES" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-03-02 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2020-03-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2020
Share Issue/Capital Change
2020-03-02 English
VOLUNTARY ANNOUNCEMENT - "SITAGLIPTIN PHOSPHATE TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-02-28 English
VOLUNTARY ANNOUNCEMENT - "BUDESONIDE SUSPENSION FOR INHALATION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-02-27 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF REGISTRATION FOR THE CLINICAL RESEARCH OF DIAMMONIUM GLYCYRRHIZINATE ENTERIC CAPSULES COMBINED WITH VITAMIN C TABLETS IN THE TREATMENT OF NOVEL CORONAVIRUS PNEU
Regulatory Filings
2020-02-26 English
VOLUNTARY ANNOUNCEMENT - "TIANQINGGANMEI" IS INCLUDED IN THE "TREATMENT PRACTICES FOR NOVEL CORONAVIRUS PNEUMONIA (SECOND EDITION)"
Regulatory Filings
2020-02-25 English
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR NEW INDICATION OF "EDARAVONE AND SODIUM CHLORIDE INJECTION" HAS BEEN ACCCEPTED
Regulatory Filings
2020-02-20 English
COMPLETION OF THE ISSUE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-02-17 English
NOTICE OF LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED - EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025 (Stock Code: 40150)
Capital/Financing Update
2020-02-17 English
VOLUNTARY ANNOUNCEMENT - "FULVESTRANT INJECTION" OBTAINS FDA ANDA APPROVAL AND GERMANY BfArM MARKETING AUTHORIZATION
Regulatory Filings
2020-02-11 English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION FOR INNOVATIVE MEDICINE "TDI01" FILED WITH AND ACCEPTED BY FDA
Regulatory Filings
2020-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2020
Share Issue/Capital Change
2020-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2020
Share Issue/Capital Change
2020-02-03 English
PROPOSED ISSUE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-01-23 English
VOLUNTARY ANNOUNCEMENT - DISTRIBUTION AGREEMENT
Regulatory Filings
2020-01-21 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "GLUCOSAMINE HYDROCHLORIDE TABLETS"
Regulatory Filings
2020-01-21 English
VOLUNTARY ANNOUNCEMENT RECEIVING THE 2019 NATIONAL SCIENCE AND TECHNOLOGY PROGRESS AWARD
Regulatory Filings
2020-01-17 English
VOLUNTARY ANNOUNCEMENT "EDARAVONE AND SODIUM CHLORIDE INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-01-14 English
VOLUNTARY ANNOUNCEMENT - "CELECOXIB CAPSULE" OBTAINS APPROVAL FOR DRUG REGISTRATION
Regulatory Filings
2020-01-09 English
VOLUNTARY ANNOUNCEMENT - "FOSAPREPITANT FOR INJECTION" OBTAINS EUROPEAN UNION MARKETING AUTHORIZATION
Regulatory Filings
2020-01-08 English
INSIDE INFORMATION - REPAYMENT OF LOAN
Capital/Financing Update
2020-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2019
Share Issue/Capital Change
2020-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2019
Capital/Financing Update
2020-01-02 English